These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 15658365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The use of novel hair testing techniques to detect highly labile components documenting heroin abuse and single dosage use of other opiates.
    Soper J.
    Aviat Space Environ Med; 2008 Apr; 79(4):451. PubMed ID: 18457307
    [No Abstract] [Full Text] [Related]

  • 7. Gatifloxacin interference with opiate urine drug screen.
    Straley CM, Cecil EJ, Herriman MP.
    Pharmacotherapy; 2006 Mar; 26(3):435-9. PubMed ID: 16503726
    [Abstract] [Full Text] [Related]

  • 8. Detecting cocaine and opiates in urine: comparing three commercial assays.
    Schilling RF, Bidassie B, El-Bassel N.
    J Psychoactive Drugs; 1999 Mar; 31(3):305-13. PubMed ID: 10533978
    [Abstract] [Full Text] [Related]

  • 9. [Urine testing in the treatment of opiate addiction].
    Ege PP.
    Ugeskr Laeger; 2003 Mar 24; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract] [Full Text] [Related]

  • 10. A leader in the field...
    DeVito RA.
    J Opioid Manag; 2015 Mar 24; 11(1):6. PubMed ID: 25881374
    [No Abstract] [Full Text] [Related]

  • 11. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL, Givone DM.
    Ann Pharmacother; 2004 Sep 24; 38(9):1525-8. PubMed ID: 15252190
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ, Walsh JM, Leaverton PE.
    J Forensic Sci; 1998 Mar 24; 43(2):395-9. PubMed ID: 9544550
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of multi-parameter opiate analysis in hair of drug users and victims of fatal poisonings.
    Kłys M, Rojek S, Kulikowska J, Bozek E, Scisłowski M.
    Przegl Lek; 2005 Mar 24; 62(6):585-90. PubMed ID: 16225130
    [Abstract] [Full Text] [Related]

  • 15. Detection of benzodiazepine abuse in opiate addicts.
    Browne R, Sloan D, Fahy S, Keating S, Moran C, O'Connor J.
    Ir Med J; 1998 Mar 24; 91(1):18-9. PubMed ID: 9563249
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of six methods for the detection of drugs of abuse in urine.
    Simpson D, Jarvie DR, Heyworth R.
    Ann Clin Biochem; 1989 Mar 24; 26 ( Pt 2)():172-81. PubMed ID: 2729861
    [Abstract] [Full Text] [Related]

  • 17. The GC-MS detection and characterization of reticuline as a marker of opium use.
    Al-Amri AM, Smith RM, El-Haj BM, Juma'a MH.
    Forensic Sci Int; 2004 Mar 10; 140(2-3):175-83. PubMed ID: 15036439
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL, Jones RT, Batki SL.
    Addiction; 1997 Mar 10; 92(3):297-302. PubMed ID: 9219391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.